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The gene expression of bovine viral diarrhea virus (BVDV), a pestivirus, occurs via translation of a hypothetical polyprotein
that is processed cotranslationally and posttranslationally by viral and cellular enzymes. A protease located in the N-terminal
region of nonstructural (NS) protein NS3 catalyzes the cleavages, leading to the release of NS4A, NS4B, NS5A, and NS5B.
Our study provides experimental evidence that histidine at position 1658 and aspartic acid at position 1686 constitute
together with the previously identified serine at position 1752 (S1752) the catalytic triad of the pestiviral NS3 serine protease.
Interestingly, a mutant protease encompassing an exchange of the active site S1752 to threonine still showed residual
activity. This finding links the NS3 protease of pestiviruses to the capsid protease of Sindbis virus. Furthermore, we observed
that the minimal protease domain of NS3 encompasses about 209 amino acids. The NS3 protease was found to be sensitive
to N-terminal truncation because a deletion of 6 amino acids significantly reduced the cleavage efficiency at the NS4A/4B
site. Larger N-terminal deletions also impaired the activity of the enzyme with respect to the other cleavage sites but to a
different degree at each site. The NS3 protease of BVDV has previously been shown to depend on NS4A as cofactor. We
demonstrate here that the central region of NS4A represents the cofactor domain. Furthermore, coprecipitation studies
strongly suggest an interaction between NS4A and the N-terminal region of NS3. Besides the remarkable similarities
observed between the pestiviral NS3 protease and the corresponding enzyme of hepatitis C virus (HCV), our results suggest
a common ancestry between these enzymes and the capsid protease of Sindbis virus. © 2000 Academic Press
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aINTRODUCTION
The genera Flavivirus, Hepacivirus, and Pestivirus con-
stitute the family Flaviviridae (Rice, 1996). Members of
the genus Pestivirus include important pathogens of live-
stock, such as classical swine fever virus (CSFV), bovine
viral diarrhea virus (BVDV-1 and BVDV-2), and border
disease virus (BDV). The single-stranded RNA genomes
of these enveloped viruses are of positive polarity and
have in general a length of 12.3 kb (Becher et al., 1998;
Collett et al., 1988b; Deng and Brock, 1992; Meyers et al.,
1989; Renard et al., 1987). The genome contains one long
open reading frame (ORF) flanked by untranslated re-
gions (UTRs). The order of the viral proteins in the hypo-
thetical polyprotein is as follows: Npro, C, Erns, E1, E2, p7,
S2-3 (NS2, NS3), NS4A, NS4B, NS5A, NS5B (Collett et
l., 1988a, 1991; Elbers et al., 1996; Meyers et al., 1992;
u¨menapf et al., 1993; Stark et al., 1993; Tautz et al., 1997;
u et al., 1997). Npro represents a nonstructural (NS)
utoprotease, which releases itself from the polyprotein
nd thereby generates the N-terminus of the capsid
rotein (C) (Stark et al., 1993; Wiskerchen et al., 1991).
he envelope glycoproteins Erns, E1, and E2, as well as
1 To whom reprint requests should be addressed at Institut fu¨r
irologie (FB 10). Justus-Liebig-Universita¨t Gieben, Frankfurter Strasse
07, D-35392 Gieben, Germany. Fax: 49-(641)-99-3-83-59. E-mail:
orbert.Tautz@vetmed.uni-giessen.de.
351the NS protein p7, are presumably released from the
polyprotein via cellular proteases (Ru¨menapf et al., 1993;
Elbers et al., 1996; N. Tautz, unpublished data).
The degree of processing at the NS2/3 site shows
remarkable variation among different pestivirus species
and strains (reviewed in Meyers and Thiel, 1996). NS2-3
and NS3 represent multifunctional proteins with pro-
tease, RNA binding, NTPase, and helicase activity
(Grassmann et al., 1999; Tamura et al., 1993; Warrener
nd Collett, 1995; Wiskerchen and Collett, 1991). The
rotease located in the N-terminal domain of NS3 leads
o the release of NS4A, NS4B, NS5A, and NS5B
Wiskerchen, 1991; see later). NS4A has recently been
stablished as cofactor of the NS3 protease (Xu et al.,
997). The functions of NS4B and NS5A are not known.
S5B represents the viral RNA-dependent RNA polymer-
se (Kao et al., 1999; Lai et al., 1999; Steffens et al., 1999;
Zhong et al., 1998).
Hepaciviruses represent the closest relatives of pes-
tiviruses, particularly with regard to the genome organi-
zation of the NS protein region and apparently also the
function or functions of individual NS proteins (Rice,
1996). In addition, for HCV NS3 represents a serine
protease that catalyzes all cleavages required for the
generation of NS4A, NS4B, NS5A, and NS5B (Barten-
schlager et al., 1993; Grakoui et al., 1993; Hijikata et al.,
1993; Tomei et al., 1993; reviewed in Bartenschlager,
0042-6822/00 $35.00
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352 TAUTZ, KAISER, AND THIEL1997). Although processing at the 3/4A site is catalyzed
exclusively in cis, all other cleavages can be mediated in
trans. The observed consensus sequence for the cleav-
age sites is: E/D-X-X-X-X-C/T 2 S/A (where X is any
amino acid and 2 symbolizes the cleavage site). The
catalytic triad of the protease is composed of histidine,
aspartic acid, and serine. Furthermore, a structurally
important Zn-binding motif was identified in the protease
domain (de Francesco et al., 1996; Kim et al., 1996; Love
et al., 1996; Stempniak et al., 1997). The minimal fragment
of NS3 still capable of cleaving at all sites was shown to
consist of a 169-amino-acid peptide located in the N-
terminal region of the protein (Bartenschlager et al., 1994;
Failla et al., 1995; Tanji et al., 1994). The NS3 protease is
ssisted by NS4A as a cofactor that stimulates the cleav-
ges at the four sites to significantly different extents
Bartenschlager et al., 1994; Failla et al., 1994; Lin et al.,
994; Steinku¨hler et al., 1996; Tanji et al., 1995a). In NS4A,
central 12-amino-acid peptide was identified that pre-
erves cofactor activity (Bartenschlager et al., 1995b; Lin
t al., 1995; Steinku¨hler et al., 1996; Tanji et al., 1995b).
oprecipitation analyses indicated a stable interaction
etween NS4A and the extreme N-terminus of NS3 (Bar-
enschlager et al., 1995a; Failla et al., 1995; Lin et al.,
1994; Satoh et al., 1995). This interaction was confirmed
by the resolution of the three-dimensional structure of
the crystallized HCV NS3 protease domain complexed
with a synthetic NS4A peptide (Kim et al., 1996).
In contrast to the NS3 protease of HCV, knowledge
about the corresponding enzyme of pestiviruses is very
limited. Two computer models, established for the pes-
tiviral enzyme (Bazan and Fletterick, 1989; Gorbalenya et
al., 1989), have been experimentally challenged so far
only by the exchange of the putative active site serine;
mutation to alanine abolished the release of NS4A,
NS4B, NS5A, and NS5B from the BVDV polyprotein
(Wiskerchen and Collett, 1991). Identification of the other
members of the catalytic triad has not been approached
experimentally. Mapping of the protease domain was
attempted (Wiskerchen and Collett, 1991) but did not lead
to valid data because the activity of the NS2-3 fragments
was determined at a site that is not processed by NS3
(Petric et al., 1992; Xu et al., 1997). At the NS3/4A site, a
restriction to cis cleavage was postulated because pro-
cessing was not observed in trans; all other cleavages
can be mediated by NS3 in trans (Wiskerchen and Col-
lett, 1991). At the NS3-dependent cleavage sites of BVDV,
a leucine residue is strictly conserved in the P1 position
(nomenclature according to Berger and Schlechter,
1970), and serine or alanine predominantly resides at the
P19 position (Tautz et al., 1997; Xu et al., 1997). Thus the
equences at the cleavage sites used by the NS3 pro-
eases of BVDV and HCV differ significantly. Moreover,
he overall degree of similarity between these enzymes
s very low on amino acid level. In contrast to HCV, no
n-binding motif can be delineated from the primaryequence of BVDV NS3. Both proteases are stimulated in
heir activity by NS4A. NS3 of BVDV strictly depends on
S4A in its activity at the NS4B/5A and NS5A/5B sites
Xu et al., 1997). The role of NS4A in the other NS3-
ependent cleavages, as well as the cofactor domain of
S4A, has not been studied so far. Our aim in the
resent study was a comprehensive characterization of
he pestiviral NS3 protease, its NS4A cofactor, and pro-
ease–cofactor interactions.
RESULTS
ctive center of the NS3 serine protease
The models proposed for the NS3 protease predict an
ctive role for serine at amino acid position 1752 (S1752)
nd for histidine at position 1658 (H1658) (Bazan and
letterick, 1989; Gorbalenya et al., 1989). Interestingly,
the models differed with respect to the third member of
the catalytic triad by predicting aspartic acid at either
position 1686 (D1686) (Gorbalenya et al., 1989) or 1695
(D1695) (Bazan and Fletterick, 1989). From the proposed
residues only S1752 was experimentally verified by an
exchange to alanine (Mendez et al., 1998; Tautz et al.,
1996; Wiskerchen and Collett, 1991).
We started our analysis of the NS3 protease of BVDV
strain CP7 with the characterization of its active center in
a transient expression study by applying the T7 vaccinia
virus system (Fuerst et al., 1986; Sutter et al., 1995). The
first set of mutants aimed at the identification of residues
that constitute the catalytic triad as well as at their
functional characterization. Mutations of S1752 to cys-
teine (S1752C) or threonine (S1752T) were introduced to
determine whether either of these amino acids could
functionally replace S1752, which serves as nucleophile.
The exchange of H1658 and aspartic acids at positions
1686/1695 by small nonpolar amino acids (glycine or
alanine, respectively) served to identify the other mem-
bers of the catalytic triad. The mutations were initially
tested in the context of a polyprotein fragment, extending
from the C-terminal region of E2 to the N-terminal part of
NS4B encoded by plasmid pE2*-4B* (Fig. 1 and Tautz et
al., 1996). The release of authentic NS2, NS3, NS2-3, and
NS4A from the polyprotein encoded by E2*-4B* (* indi-
cates truncated proteins) has been demonstrated before
in the T7 vaccinia system (Tautz et al., 1996). Moreover,
the use of this short polyprotein fragment facilitated the
detection of noncleaved protein species. In the S1752A
mutant, included as a control, the partial cleavage of
NS2-3, which is independent of the NS3 protease, still
occurred (Tautz et al., 1996), whereas the NS3 protease-
dependent cleavages at the NS3/4A, NS2-3/4A and
NS4A-4B* sites were abrogated. As a consequence,
NS3-4B* and NS2-4B* with apparent molecular masses
of 92 and 150 kDa, respectively, appeared. These pro-
teins could be precipitated by antisera specific for NS3
or NS4 (Tautz et al., 1996, and Fig. 2, lanes 3 and 4). In the
t bolizes
h erine p
353BVDV NS3 SERINE PROTEASEanalyses shown in Fig. 2, the amount of NS3-4B* was
used as a parameter to monitor the impairment of the
serine protease.
The S1752C exchange in construct pE2*-4B* led to an
efficient release of NS3 and to the generation of a small
amount of NS3-4B* (Fig. 2, lane 5). By comparison, ex-
change S1752T caused an accumulation of NS3-4B*,
which illustrates the severely reduced activity of this
FIG. 1. Schematic diagram of the BVDV CP7 polyprotein (upper par
runcated proteins are marked by *. The shadowed bar INSERTION sym
as been shown to induce NS2-3 cleavage independent of the NS3 s
FIG. 2. Single amino acid substitutions in the serine protease domain
of NS3 and cleavage at the NS3/4A site. Expression of the E2*-4B*
region of the BVDV polyprotein from transfected plasmids was
achieved by the use of a recombinant vaccinia virus expressing the T7
RNA polymerase (MVA-T7pol; Sutter et al., 1995). The metabolically
labeled proteins were immunoprecipitated with antisera against NS3 or
NS4, respectively, and further analyzed by SDS–PAGE (Doucet and
Trifaro, 1988) and fluorography. The transfected expression plasmids
as well as the antisera used are indicated above the corresponding
lanes. Mutations in the encoded CP7 polypeptides are indicated in the
names of the corresponding plasmids. Precipitates derived from cells
infected with MVA-T7pol without plasmid transfection are separated in
lane 13 (Mock). The positions of NS2-3, NS3, and NS3-4B* are indicated
by arrowheads on the left. The positions of the mass standards
([14C]MW markers) are shown on the right; k 5 kDa.mutant. Unexpectedly, a substantial amount of NS3 was
still generated (Fig. 2, lane 7). The H1658A exchange in
contrast completely abrogated the generation of mature
NS proteins (Fig. 2, lanes 9 and 10); this result was in line
with the postulated catalytic role of H1658 in the NS3
protease.
Surprisingly, neither mutation D1686G (Fig. 2, lanes 11
and 12) nor exchange D1695A (data not shown) induced
obvious changes in processing. Only for mutant D1686G
did a minor band corresponding to NS3-4B* appear. This
result, which was obtained mainly by monitoring the
cleavage activity at the NS3/4A site, thus did not allow
establishment of the third member of the catalytic triad.
To identify the respective residue, we introduced ex-
changes D1686G and D1695A into a polyprotein that
extended from E2* to NS5B encoded by plasmid pE2*-5B
(Fig. 1). This setup allows to monitor the effect of muta-
tions on the trans cleavages at sites NS4A/4B, NS4B/5A,
and NS5A/5B. The transfection of plasmids pE2*-5B and
pE2*-5B/D1695A led to the generation of all viral NS
proteins (Figs. 3A and 3B, lanes 2 and 6, and data not
shown), whereas the D1686G exchange completely in-
hibited the trans cleavages of the NS3 protease (Figs. 3A
and 3B, lane 5); as expected, the cleavage at the NS3/4A
site was almost unaffected (data not shown).
Furthermore, we examined the effect of mutations
S1752C and S1752T on the trans cleavage activity of the
protease. After the transient expression of pE2*-5B/
S1752C or pE2*-5B/S1752T, minor amounts of NS2-3 and
NS3 (data not shown), but neither NS4A, NS4B, NS5A,
nor NS5B, could be detected (Figs. 3A and 3B, lanes 3
and 4, respectively). According to this assay system, the
respective NS3 protease mutants exhibited only cleav-
age activity at the NS3/4A site.
Taken together, our results are in agreement with the
model of Gorbalenya et al. (1989) that predicted for the
he parts encoded by T7 expression plasmids pE2*-4B* and pE2*-5B;
the 9-amino-acid insertion present in NS2 of BVDV CP7. This sequence
rotease.t) and tNS3 protease a catalytic triad composed of H1658,
D1686, and S1752.
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354 TAUTZ, KAISER, AND THIELCharacterization of the NS3 protease domain
For several BVDV strains, it has been experimentally
demonstrated (Ku¨mmerer et al., 1998; Meyers et al.,
1998) or suggested (Mendez et al., 1998; Meyers and
Thiel, 1996; Tautz et al., 1993) that the first amino acid of
NS3 is glycine 1590. Accordingly, authentic NS3 encom-
passes amino acids 1590–2272 of the BVDV polyprotein
(Tautz et al., 1997; Xu et al., 1997). Our next aim was to
urther define the protease domain of NS3. We started
he corresponding analysis by the construction of ex-
FIG. 3. NS3 protease mutants and processing of E2*-5B. (A) Detec-
tion of NS4A and NS4B. Immunoprecipitates obtained by the use of
NS4 specific antiserum were separated by Tricine–SDS–PAGE (Scha¨g-
ger and Jagow, 1987). Samples derived from cells infected with MVA-
T7pol without plasmid transfection were separated in lane 7 (Mock).
Arrowheads indicate the position of NS4A and NS4B. The 38-kDa
protein (lower band of the doublet) in lanes 2 and 6 most likely
represents noncleaved NS4A-4B (see also Fig. 5C). The amount of NS2
detected on transfection of the different plasmids was used to stan-
dardize transfection efficiencies (data not shown). The S1752A ex-
change was included as a control to show inhibition of NS3-dependent
cleavages. (B) Detection of NS5A-5B, NS5A, and NS5B. The transfected
expression plasmids are depicted in the figure above the correspond-
ing lanes. For immunoprecipitation, NS5-specific antisera were used.
Arrowheads at the left indicate positions of NS5A-5B, NS5A, and NS5B.
Precipitates derived from cells infected with MVA-T7pol without plas-
mid transfection were separated in lane 7 (Mock).ression plasmids encoding C-terminally truncated NS3
olecules, which encompass 251, 211, or 171 amino
r
tcids from the NS3 region; the C-terminal amino acid of
hese NS3 derivatives encoded by pGST-NS3-1840,
GST-NS3-1800, or pGST-NS3-1760 (Fig. 4A) is located in
he polyprotein at the positions indicated by the plasmid
ames. The NS3 fragments were expressed as glutathi-
ne-S-transferase (GST) fusion proteins to ease their
etection (Figs. 4A and 4B). The substrate for the pro-
ease was expressed from pNS4A-5B-myc (Fig. 4A) en-
oding an NS4A-5B polyprotein fragment with a C-termi-
al myc-tag; the latter facilitates protein detection. On the
oexpression of NS4A-5B-myc with GST-NS3-1800 or
ST-NS3-1840, a polypeptide with an apparent molecu-
ar mass expected for NS5B-myc (about 75 kDa) could be
etected with the myc-tag-specific antibody (Fig. 4C,
anes 3 and 4). In contrast, cotransfection of pGST-NS3-
760 and pNS4A-5B-myc did not result in the cleavage of
S4A-5B-myc (Fig. 4C, lane 2). The expression of the
ST-NS3 fusion proteins in the respective cell lysates
as also verified by Western blotting (data not shown).
he use of identically truncated NS3 molecules devoid of
he GST fusion led to comparable results, which demon-
trates that the fusion partner had no influence on the
btained results (data not shown). Accordingly, the C-
erminal border of the NS3 serine protease domain re-
ides between amino acid positions 1760 and 1800 at
east with respect to cleavage at the NS5A/5B site.
To determine the N-terminal border of the protease
omain, we chose a strategy that allowed the expression
f N-terminally truncated NS3 molecules without any
ector-derived amino acid at their N-termini. For this
urpose, one ubiquitin monomer was inserted upstream
f the BVDV polyprotein. On expression, cellular ubiq-
itin-specific proteases (Jonnalagadda et al., 1989;
ayer and Wilkinson, 1989; Rose, 1988) will cleave after
he C-terminal amino acid of ubiquitin (glycine 76) and
hereby generate the N-terminus of NS3. It has previ-
usly been demonstrated that this cleavage also occurs
fficiently in the context of the BVDV polyprotein (Tautz et
l., 1993). The BVDV polyprotein encoded by plasmid
Ub1590-5B starts with the first amino acid of NS3 (G1590)
nd proceeds to the end of NS5B (Fig. 5A). In a series of
erivatives of pUb1590-5B, the N-terminus of NS3 was
runcated by 2, 6, 20, 35, and 45 amino acids (Fig. 5A); the
umbers in the names of the constructs reflect the rela-
ive position of the first amino acid of the encoded BVDV
olypeptide with respect to the viral polyprotein. After the
ransfection of pUb1590-5B and pUb1592-5B, viral pro-
eins NS3, NS4A, NS4B, NS5A, and NS5B could be de-
ected (Figs. 5B and 5C). The deletion of the 6 N-terminal
mino acids resulted in the appearance of an additional
rotein of about 38 kDa, which could be precipitated by
ntibodies against NS4 (Fig. 5C, lane 3). Due to its
pparent molecular mass and the strong decline in the
mount of NS4A and NS4B, this protein most likely rep-esents noncleaved NS4A-4B. On the deletion of 20 N-
erminal amino acids, only two mature viral proteins were
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NS4A-5B-myc, NS5B-myc, and the cellular myc protein (c-myc) are
355BVDV NS3 SERINE PROTEASEreleased from the polyprotein, namely NS3 (Fig. 5B, lane
7) and a minor amount of NS5B (Fig. 5B, lane 8). The
additional proteins with apparent molecular masses of
about 95 and 160 kDa, respectively, could be precipitated
with an NS5-specific antiserum (Fig. 5B, lane 8) and by
the serum directed against NS4 (data not shown) but not
with antibodies specific for NS3 (Fig. 5B, lane 7). In
accordance with their apparent molecular masses and
reactivity with defined antibodies, these proteins most
likely represent NS4A-5A and NS4A-5B. The transfection
of pUb1625-5B (deletion of 35 N-terminal amino acids)
resulted in the generation of the truncated NS3 as the
only mature viral protein; this NS3 derivative migrates
due to its truncation significantly faster than authentic
NS3 (Fig. 5B, lane 9). In addition; NS4A-5A and NS4A-5B
were precipitated by the antisera specific for NS5 (Fig.
5B, lane 10). The appearance of these proteins indicates
that cleavage still takes place at the NS3/4A and
NS5A/5B sites, albeit at a very low level. The failure to
detect NS5B might be due to the low cleavage efficiency
and the described inherent instability of NS5B (Collett et
al., 1991). The deletion of the first 45 amino acids of NS3
abolished the activity of the protease because neither
one of the mature BVDV proteins nor NS4A-5A and
NS4A-5B could be identified (Figs. 5B, lanes 11 and 12,
and 5C, lane 6).
Cofactor domain of NS4A
NS4A, which encompasses amino acids 2273–2336 of
the BVDV polyprotein (Tautz et al., 1997; Xu et al., 1997),
cts as an essential cofactor of the NS3 protease, at
east for the cleavages at sites NS4B/5A and the
S5A/5B sites (Xu et al., 1997). To determine whether the
omplete NS4A protein is necessary to activate the pro-
ease, we established an appropriate cleavage assay.
NS5A-5B-myc (Fig. 6A) was used for the expression of
suitable substrate. On the transfection of plasmid
NS2*-3* (Fig. 6A), an NS3-specific antibody detected
roteins NS2*-3* and NS3* (data not shown). The NS4A-
erived peptides were expressed as fusions to GST to
llow their detection by Western blotting (Fig. 6C). As
xpected, the cotransfection of pNS2*-3* and pNS5A-5B-
yc in the absence of the cofactor NS4A did not lead to
etectable cleavage at the NS5A/5B site (Fig. 6B, lane 1).
fter the cotransfection of plasmids pNS2*-3* and
NS5A-5B-myc with pGST-NS4A fusion proteins encom-
assing either complete NS4A together with a small
art of the NS4B coding region (pGST-NS4A-2349,
indicated at the left. In lane 5 (Mock), lysates of cells infected only with
MVA-T7pol virus were separated. The lanes combined in the figureFIG. 4. C-terminal border of the NS3 protease domain. (A) Scheme of
the used cDNA constructs. The C-terminally truncated NS3 derivatives
were expressed from plasmids pGST-NS3-1840, pGST-NS3-1800, or
pGST-NS3-1760 as fusions to GST. Plasmid pNS4A-5B-myc encodes
the NS protein region from NS4A-5B with an myc-tag fused to the
C-terminus. The numbers in brackets indicate the amino acids of the
BVDV polyprotein encoded by the respective construct. (B) Western blot
analysis of the GST-NS3* fusion proteins. Plasmids pGST-NS3-1840,
pGST-NS3-1800, or pGST-NS3-1760 were transfected into cells previ-
ously infected by MVA-T7pol virus. The respective cell lysates were
separated by Tricine–SDS–PAGE (Scha¨gger and Jagow, 1987) and an-
alyzed by Western blotting with a mouse mAb directed against GST
(Santa Cruz Biotechnology). The lanes combined in the figure were
derived from the same gel. Lysates of cells only infected with MVA-
T7pol virus were separated in lane 4 (Mock). The positions of the mass
standards (prestained MW markers) are shown on the right; k 5 kDa.
(C) Proteolytic activity of the GST-NS3* fusion proteins. On coexpres-
sion of GST-NS3-1840, GST-NS3-1800, or GST-NS3-1760 and the NS4A-
5B-myc substrate, the respective lysates were analyzed by Tricine–
SDS–PAGE (Scha¨gger and Jagow, 1987) and Western blotting applyingwere derived from the same gel. On the right, the positions of the mass
standards (prestained MW markers) are shown; k 5 kDa.
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356 TAUTZ, KAISER, AND THIELpGSTNS4A-2339) (Fig. 6B, lanes 2 and 3) or an NS4A
fragment with a 7-amino-acid deletion at its C-termi-
nus (pGST-NS4A-2329) (Fig. 6B, lane 4), NS5B-myc
FIG. 5. N-terminal border of the NS3 protease domain. (A) Schem
rganization of the polyprotein encoded by the expression plasmids is d
f the figure, the amino acid sequence at the cleavage site between u
irst amino acid of the encoded NS3 derivative is indicated by the plas
ellular ubiquitin specific proteases are known to cleave downstream
ollows the C-terminal amino acid of ubiquitin. We did therefore not g
-terminus. The right part of the figure summarizes the obtained results
xpression of NS3–5B and N-terminally truncated derivatives. After tran
accinia virus system, the cell lysates were subjected to a radioimmuno
ndicated. In lanes 12 and 13 (Mock), precipitates generated from lysa
S5B, NS4A-5A, and NS4A-5B are indicated by arrowheads. The positio
(C) Processing at NS3/4A and NS4A/4B sites. After transient express
antibodies. Precipitates were separated by Tricine–SDS–PAGE (Scha¨
infected with MVA-T7pol virus. The positions of NS4A, NS4B, and NS4
markers) are shown on the right; k 5 kDa. The results concerning pro
plasmids described above; the corresponding constructs encoded NSwas released. Larger C-terminal truncations (17 amino
acids or more) of NS4A abrogated its cofactor activity.NS4A truncated N-terminally by 9 amino acids still
assisted in NS5A-5B-myc cleavage (Fig. 6B, lane 8). As
indicated by the very weak appearance of NS5B-myc
wing of the cDNA constructs. In the upper part of the scheme, the
d. In all clones, ubiquitin resides upstream of NS3. In the lower left part
n and NS3 is given in the one-letter code. The relative position of the
me. The C-terminal tripeptide of ubiquitin, namely (RGG), is indicated.
sequence. This cleavage is strongly impaired only if a proline residue
an NS3 derivative in which just 1 amino acid was deleted from the
icient cleavage; 2, no cleavage; (1), inefficient cleavage. (B) Transient
xpression in the presence of [35S]methionine/cysteine by use of the T7
itation analysis. The transfected plasmids and the utilized antisera are
VA-T7pol-infected cells were separated. The positions of NS3, NS5A,
e mass standards ([14C]MW markers) are shown on the right; k 5 kDa.
ll lysates were further processed by precipitation using NS4-specific
d Jagow, 1987). Lane 7 (Mock) represents an analysis of cells only
e indicated on the left. The positions of the mass standards ([14C]MW
g at the NS3/4A site were confirmed by the use of derivatives of the
data not shown).atic dra
epicte
biquiti
mid na
of this
enerate
: 1, eff
sient e
precip
tes of M
ns of th
ion, ce
gger an
A-4B arNS4A with a deletion of 18 amino acids from the
N-terminus still retained residual cofactor activity (Fig.
D
W
p on the
357BVDV NS3 SERINE PROTEASE6B, lane 9). The minimal NS4A fragment that preserves
the cofactor function in cleavage at the NS5A/5B site
thus is probably composed of not more than amino
acids 2291–2329 even though a direct test with a
corresponding peptide was not performed. Compara-
ble results were also obtained with NS4A fragments
FIG. 6. Cofactor domain of NS4A. (A) Scheme of expressed proteins
pNS5A-5B-myc served for generation of a suitable substrate for cofact
GST fused to NS4A served for detection of individual proteins. Numbe
respective plasmids. (B) NS4A-dependent cleavage assay. After coexpr
lysates were subjected to Western blot analysis. Proteins were separa
myc-tag-specific mAb. In lane 11 (Mock), lysates of cells infected only w
the cellular myc protein (c-myc) are indicated. On the right, the positio
etection of the GST-NS4A fusion proteins. The cell lysates describe
estern blot analysis applying an mAb directed against GST. In lane
ositions of the mass standards (prestained MW markers) are shownwithout GST-tag (data not shown).Interaction between NS4A and the N-terminal domain
of NS3
In the HCV system, a stable interaction between the
NS4A cofactor domain and the N-terminal region of NS3
has been established (Bartenschlager et al., 1995a; Failla
*-3* was used to produce NS2*-3* and NS3* in the absence of NS4A.
ndent proteolysis. The myc-tag at the C-terminus of NS5B as well as
arentheses indicate the part of the BVDV polyprotein encoded by the
of NS2*-3*, NS5A-5B-myc, and the different NS4A derivatives, the cell
Tricine–SDS–PAGE and further analyzed by Western blotting using an
-T7pol were analyzed. The positions of NS5A-5B-myc, NS5B-myc, and
e mass standards (prestained MW markers) are shown; k 5 kDa. (C)
e (see legend for Fig. 6B) were analyzed by Tricine–SDS–PAGE and
ck), lysates of cells infected only with MVA-T7pol were analyzed. The
right; k 5 kDa.. pNS2
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358 TAUTZ, KAISER, AND THIELwhether a similar NS3/NS4A interaction occurs in the
BVDV system. Accordingly, plasmids pUb1590-4A and its
derivatives encoding N-terminally truncated NS3-4A mol-
ecules were generated by the deletion of the NS4B-5B
coding region from the series of plasmids based on
pUb1590-5B. Proteins expressed in the presence of
[35S]methionine/cysteine by pUb1590-4A and its deriva-
ives were immunoprecipitated under nondenaturing
onditions with a monoclonal antibody (mAb) directed
gainst NS3. SDS–PAGE analysis and fluorography of
he precipitated proteins revealed that a 7-kDa protein
oprecipitated with full-length NS3 (Fig. 7, lane 1). A
estern blot analysis carried out in parallel identified the
-kDa protein as NS4A (data not shown). Although NS4A
ould also be coprecipitated with the NS3 derivative,
hich was N-terminally truncated by 2 amino acids (Fig.
, lane 2), all NS3 species with larger N-terminal trunca-
ions did not allow pulling down NS4A under the chosen
onditions (Fig. 7). These data are in line with an essen-
ial role of the N-terminal region of NS3 in the complex
ormation between NS3 and NS4A.
DISCUSSION
The aim of the present study was the characterization
f the pestiviral NS3 protease. As a first step, the resi-
ues constituting the catalytic triad were determined.
he obtained results are in agreement with the model of
orbalenya et al. (1989), in which the catalytic triad is
omposed of H1658, D1686, and S1752. There was no
ndication for an essential role of D1695 in the protease
omain as proposed in an alternative model (Bazan and
letterick, 1990).
The NS3 serine protease catalyzes two types of
FIG. 7. Coprecipitation of NS3 and NS4A. Proteins encoded by
pUbNS3-4A and its derivatives were transiently expressed in the pres-
ence of [35S]methionine/cysteine by using MVA-T7pol virus. Cell lysates
were prepared under nondenaturing conditions and subjected to im-
munoprecipitation by an NS3-specific mAb. The obtained aggregates
were denatured, separated by Tricine–SDS–PAGE, and processed for
fluorography. The positions of NS3 and NS4A are indicated.leavages. Although processing at the NS3/NS4A site
s believed to occur exclusively in cis, all other cleav-
t
iges can be mediated in trans (Wiskerchen and Col-
ett, 1991). Studies on the kinetics of proteolysis of the
S region of the BVDV polyprotein in virus-infected
ells indicated that the cleavage at the NS3/4A site
akes place with significantly higher efficiency and
aster kinetics than the other NS3-mediated cleavages
Collett et al., 1991). Our study revealed that the NS3
utants carrying exchanges S1752C, S1752T, or
1686G, respectively, still catalyzed the NS3-4A cleav-
ge, whereas they showed no activity at the other
leavage sites in our assay system. With respect to the
igher activity of the protease at the NS3/4A site, we
ssume that an overall reduction in the enzymatic
ctivity due to the introduced mutations can result in
he observed selective loss of trans cleavage activity.
The finding that serine and cysteine are interchange-
ble as nucleophiles, at least to some extent, has al-
eady been described for other viral serine proteases
Hahn and Strauss, 1990; see later) as well as viral
erine-like cysteine proteases such as the 3C protease
f picornaviruses and the 27-kDa NIa protease of the
otyvirus tobacco etch virus (Dougherty et al., 1989; Law-
on and Semler, 1991). It was surprising, however, that
S3 with the S1752T substitution exhibited a significant
esidual protease activity at the NS3/4A site, which indi-
ates that the hydroxyl group of threonine serves in the
ucleophilic attack during proteolysis. There is only one
ther example of a serine protease where the exchange
f the active site serine by threonine gave rise to an
nzyme with substantial protease activity (10% of wild
ype), namely, the capsid protease of Sindbis virus (Hahn
nd Strauss, 1990). This enzyme is an autoprotease that
atalyzes its release from the viral polyprotein, thereby
enerating its own C-terminus. It was supposed that the
ctivity of the capsid protease with a threonine in the
ctive site is due to the intramolecular nature of the
eaction and the very fast reaction kinetics of the wild-
ype protease (Hahn and Strauss, 1990). Furthermore, for
he Sindbis virus capsid protease as well as the BVDV
nzyme, the exchange of the active site aspartic acid did
ot significantly reduce their cis cleavage activities. In
ddition to the similarities observed in this study with
egard to the biochemistry of these enzymes, it turned
ut recently that the three-dimensional structure of the
S3 protease of HCV, a close relative of pestiviruses,
hares its greatest structural similarity with the Sindbis
irus capsid protease (Kim et al., 1996). These findings
icely corroborate the relationship between the de-
cribed proteases, which remarkably was postulated
everal years ago on the basis of computer-assisted
equence comparisons of flaviviruses, pestiviruses, and
lphaviruses (Gorbalenya et al., 1989).
According to our study, a 209-amino-acid fragment of
he BVDV NS3 serine protease is still capable of exerting
he NS5A-NS5B cleavage. A protease domain of this size
s in agreement with the data obtained for the NS3
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359BVDV NS3 SERINE PROTEASEprotease domains of HCV (169 amino acids) (Barten-
schlager et al., 1994; Failla et al., 1995; Tanji et al., 1994)
and members of the genus Flavivirus (e.g., yellow fever
virus, 181 amino acids; Chambers et al., 1990). Because
fusions of GST to the N-terminus of NS3 had no delete-
rious effect on the activity of the enzyme, the folding of
the NS3 protease domain can apparently occur indepen-
dent of the preceding peptide sequence.
The sensitivity of the protease domain to N-terminal
truncations and the stepwise loss of activity are remark-
able: a deletion of 6 N-terminal amino acids resulted in a
strongly reduced activity at the NS4A/4B site (Figs. 5B
and 5C). Larger N-terminal truncations of NS3 further
reduced the activity of the enzyme at the individual cleav-
age sites to different extents. The greatest tolerance to
N-terminal truncation of the protease was observed for
the cis cleavage and processing at the NS5A/5B site.
Interestingly, similar results have been obtained in the
HCV system for N-terminally truncated NS3 protease
derivatives. Short deletions selectively interfered with
NS4A-NS4B and NS4B-NS5A cleavage, whereas more
extensive truncations of NS3 also inhibited cleavage at
the NS5A/5B site and ultimately the cis cleavage at the
NS3/4A site (reviewed in Bartenschlager, 1997).
Our coprecipitation study revealed an interaction be-
tween BVDV proteins NS3 and NS4A, which was abro-
gated by a deletion of the first 6 amino acids of NS3 (Fig.
7). This finding strongly suggests a role of the N-terminal
domain of NS3 in NS4A binding. Interestingly, such a
truncated protease was proteolytically active at all sites.
For HCV, binding of NS4A to the N-terminal region of NS3
has also been demonstrated by coprecipitation and was
confirmed at the structural level (Kim et al., 1996). This
interaction could be abrogated by N-terminal truncations
of NS3 (Bartenschlager et al., 1995a; Failla et al., 1995;
Lin et al., 1994; Satoh et al., 1995). N-terminally truncated
as well as mutagenized NS3 derivatives could be iden-
tified that show proteolytic activity despite impaired
NS4A binding. These data and the results obtained in
this study suggest that a weak transient protease–cofac-
tor interaction seems to be sufficient for activation of the
NS3 proteases of HCV (for review, see de Francesco and
Steinku¨hler, 2000) and BVDV.
Taken together, our study revealed striking parallels
between the NS3 proteases of BVDV and HCV, especially
with respect to active site residues, size of protease
domain, NS4A cofactor dependency, and NS3–NS4A in-
teraction. These findings again underline the fascinat-
ingly close relationship of pestiviruses and hepacivi-
ruses. In addition, the similarities observed between the
capsid protease of Sindbis virus, a member of the genus
Alphavirus, and the NS3 protease of a member of the
Flaviviridae suggest a common ancestor for the serine
proteases of these positive-strand RNA viruses.
c
pMATERIALS AND METHODS
Cells and viruses
BHK-21 cells were kindly provided by J. Cox (Federal
Research Center for Virus Diseases of Animals, Tu¨bingen,
Germany). Cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal calf serum
(FCS). The recombinant vaccinia virus expressing the T7
RNA polymerase [modified virus Ankara (MVA)-T7pol] was
generously provided by G. Sutter (Institut fu¨r Molekulare
Virologie, GSF-Forschungszentrum fu¨r Umwelt und Ge-
sundheit GmbH, Oberschleibheim, Germany).
ransient expression with the T7 vaccinia virus
ystem
BHK-21 cells (5 3 105, 3.5-cm dish) were infected with
VA-T7pol at a multiplicity of infection of 5 in medium
acking FCS. After 1 h of incubation at 37°C, cells were
ashed twice with medium lacking FCS followed by
NA transfection with 2 mg plasmid DNA by the use of
uperfect (Qiagen, Hilden, Germany) according to the
rotocol of the manufacturer. For Western blot analysis,
he transfected cell cultures were harvested about 6 h
osttransfection (p.t.).
Radioactive labeling of cells. At 2 h p.t., cells were
ashed two times with PBS and incubated with 1 ml of
abel medium lacking cysteine and methionine for 0.5 h
t 37°C. After the addition of 500 mCi of [35S]methionine/
cysteine ([35S]-Pro Mix; Amersham, Freiburg, Germany),
rotein expression was allowed to proceed for an addi-
ional 4 h at 37°C. After washing with PBS, cells were
tored at 270°C until they were further processed.
adioimmunoprecipitation and SDS–PAGE
Immunoprecipitation under denaturing conditions. Cell
xtracts prepared in the presence of 2% SDS were di-
uted and incubated with 5 ml of undiluted antiserum. For
he formation of precipitates, protein A–agarose (Calbio-
hem, La Jolla, CA) was used. SDS–PAGE analysis of
roteins was performed by the use of Tricine gels
Scha¨gger and Jagow, 1987) or according to Doucet and
rifaro (1988). Gels were processed for fluorography us-
ng En3Hance (New England Nuclear, Boston, MA).
Immunoprecipitation under nondenaturing conditions.
ells were lysed with buffer IBP150 [20 mM Tris–HCl, pH
.0, 150 mM KCl, 1% Nonidet P-40, 1 mM EDTA, pH 8.0, 1
M EDTA, 0.1 mM Pefablock SC (Roche Diagnostics,
annheim, Germany)] kept on ice for 5 min and slowly
otated for 30 min at 4°C. Insoluble parts were removed
y two consecutive centrifugations at 300 and 10,000 g.
S3-specific mAb 8.12.7 (Corapi et al., 1990) was bound
ia Fc-specific anti-mouse IgG (Sigma Chemical Co., St.
ouis, MO) to protein A–agarose (Calbiochem) and
ross-linked by diaminopimelic acid according to the
rotocol of Harlow and Lane (1988). The cross-linked
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360 TAUTZ, KAISER, AND THIELantibody was incubated with the cleared cell lysates for
1 h at 4°C. Complexes were collected by centrifugation
at 4000 g and washed once with IBP150 and twice with
BP500 (20 mM Tris–HCl, pH 8.0, 500 mM KCl, 1% Non-
det P-40, 1 mM EDTA, pH 8.0, 1 mM EDTA, 0.1 mM
efablock SC). After a final washing step with IBP150, the
recipitate was diluted in gel loading buffer containing
% SDS and 5% mercaptoethanol and boiled for 5 min.
olymerase chain reaction (PCR)
For PCR, a GENIUS thermocycler (Techne/thermo-
UX, Wertheim, Germany) was used. Standard condi-
ions used for DNA-based amplifications have been de-
cribed previously (Tautz et al., 1999).
ucleotide sequencing
Sequencing was carried out with the Thermo Seque-
ase Cycle Sequencing Kit (Amersham Buchler, Braun-
chweig, Germany). The primers used for sequencing
ere labeled with infrared dye IRD41 (MWG-Biotech,
bersberg, Germany). Analyses of sequencing gels were
arried out with an automatic sequencer LI-COR 4000L
MWG-Biotech, Ebersberg, Germany).
estern blotting
After SDS–PAGE proteins were transferred onto nitro-
ellulose membranes (Optitran BA-S83 Reinforced NC;
chleicher & Schuell, Du¨ren, Germany). Blocking was
arried out with 2% dry milk in PBS for 1 h. The proteins
ere visualized by chemiluminescence (SuperSignal;
ierce Chemical, Rockford, IL).
onstruction of the expression plasmids
All BVDV cDNAs used for the construction of the ex-
ression plasmids throughout this study are derived from
VDV strain CP7 (Meyers et al., 1996; Tautz et al., 1996).
For PCR amplifications used in the construction of the
expression plasmids, the already described BVDV CP7
cDNA clones were used as templates (Meyers et al.,
1996; Tautz et al., 1996, 1997). Numbering of nucleotides
or amino acids occurs throughout this report with re-
spect to the BVDV SD-1 sequence because the complete
sequence of BVDV CP7 has not been published yet and
SD-1 represents the only complete BVDV sequence de-
void of a strain-specific insertion (Deng and Brock, 1992).
pE2*-4B*. This plasmid has already been described
under the name pC7.1 (Tautz et al., 1996); in the same
publication, the generation of construct pC7PM1 was
described. The latter construct is termed pE2*-4B*/
S1752A in this report to obtain a uniform nomenclature.
The other mutations in the active center of the NS3
protease were generated by standard PCR techniques
using oligonucleotide primers that encompass the indi-
vidual nucleotide exchanges.pE2*-5B. Elongation of the BVDV CP7 cDNA in pC7.1 at
its 39 end by a fragment derived from construct pC7.3898
(Tautz et al., 1997) resulted in plasmid pE2*-5B. Thus the
BVDV ORF encoded by this plasmid starts with codon
967 and ends with the authentic stop codon encom-
passed in the BVDV genome.
pNS4A-5B-myc. This plasmid is based on pCITE-2A
(Novagene, La Jolla, CA), which downstream of a T7 RNA
polymerase promoter encompasses an internal ribo-
somal entry site (IRES) of the encephalomyocarditis virus
(EMCV). The 59 end of the cDNA insert in this plasmid
was generated by PCR and starts downstream of the
vector-derived AUG codon with an alanine codon fol-
lowed by the BVDV ORF beginning with the codon for
serine 2274, the second amino acid of NS4A; the cDNA
proceeds downstream to the NS5B gene. Into a PvuII site
(nucleotides 12260–12265) in the 39 region of the 5B
gene, an EcoRV–PvuII fragment derived from pSecTag
(Invitrogen, Groningen, Netherlands) was cloned; the re-
spective fragment encompassed part of the polylinker
and the coding sequence for an myc- and a His-tag
followed by a stop codon. In the polyprotein encoded by
pNS4A-5B-myc, accordingly the 6 C-terminal amino ac-
ids of NS5B are substituted by 34 pSecTag-derived
amino acids, including the myc-epitope.
pGST-NS3-1760/1800/1840. The GST gene from
pGEX-2T (Pharmacia) was amplified by PCR and inte-
grated into the NcoI site of pCITE-2A by standard cloning
techniques. Downstream of the GST gene, the resulting
plasmid, pCITE-GST, contains a singular NcoI site en-
compassing an in-frame AUG codon. After restriction
with NcoI–XbaI, this vector was ligated to an NcoI–XbaI
fragment of pARC7 (Tautz et al., 1997). The resulting
plasmid, pGST-NS3-2351, encoded for the CP7 polypro-
tein from amino acids 1587–2351. To generate the final
constructs, PCR-derived fragments of the NS3 gene of
CP7 that encode stop codons downstream of serine
1760, lysine 1800, or leucine 1840, respectively, were
used to substitute an HpaI–XbaI (nucleotides 5434–5439/
polylinker) fragment in pGST-NS3-2351.
pUb1590-5B. From plasmid FsubiNS3 (Tautz et al.,
1999), which encompasses the mouse ubiquitin gene
(ubi), an NcoI (first codon of ubiquitin)–AgeI (BVDV nu-
cleotides 5312–5316) fragment was used to replace a
corresponding NcoI–AgeI fragment of pC7.3898 (Tautz et
al., 1997), which resulted in the final construct pUb1590-
5B. In this plasmid, the NS3 gene, starting with the codon
for glycine 1590, is preceded by the 39 end of the ubiq-
uitin gene, including an SacII site. To generate the de-
rivatives that encode N-terminally truncated NS3 mole-
cules downstream of the ubiquitin, the SacII (39 end of
ubiquitin gene)–AgeI (BVDV nucleotides 5312–5316) frag-
ment was replaced by corresponding PCR-derived frag-
ments; the sense primers used for the generation of the
respective PCR products encompassed the 39 end of ubi,
including an SacII site and the 59 region of the truncated
dd
361BVDV NS3 SERINE PROTEASENS3 gene. According to this scheme, plasmids pUb1592-
5B, pUb1596-5B, pUb1596-5B, pUb1610-5B, pUb1625-5B,
and pUb1635-5B were established. The plasmid names
indicate the first amino acid of the BVDV polyprotein that
is located downstream of ubiquitin.
For cloning of pUb1590-4A, an NcoI–MscI (ubi start
codon/BVDV nucleotides 7136–7141) fragment of
pUb1590-5B was inserted into pCITE-2A restricted with
NcoI–HincII. Into this plasmid, the CP7 cDNA down to
the 39 end of the NS4A gene (codon 2336) was inserted
together with a stop codon by PCR and standard cloning
techniques. Constructs pUb1592-4A, pUb1596-4A,
pUb1610-4A, pUb1625-4A, and pUb1635-4A were gener-
ated as described for the derivatives of pUb1590-5B by
the use of SacII and AgeI fragments.
pNS5A-5B-myc. For PCR amplification of the NS5A-B
region, pE2*-5B-myc served as DNA template. The re-
sulting PCR product encompassed a primer derived NcoI
site (including the start AUG) that is followed by a glycine
codon and the BVDV ORF beginning with codon 2586.
The final construct, pNS5A-5B-mcy, was created by the
replacement of an NcoI (start AUG)–PstI (8682–8686)
fragment of pNS4A-5B-myc by an identically restricted
fragment of the PCR fragment described earlier.
pGST-NS4-2350. The basic plasmid for this construct
and its derivatives is pCITE-GST (see ear.ier). Into the
ORF of this vector, PCR-derived fragments that contain
parts of the NS4A-NS4B region were integrated by stan-
dard cloning techniques. In clones pGST-NS4A-2349/-
2339/-2329/-2319/-2309/-2299, the 59 end of the BVDV
cDNA is identical to that of pNS4A-5B-myc (see earlier).
The last amino acid of the BVDV polyprotein encoded by
the respective construct is illustrated by the plasmid
name. For pGST-2281-2349, pGST-2291-2349, and pGST-
2300-2349, the names of the constructs indicate the
encoded fragments of the BVDV polyprotein downstream
of the GST gene.
Antisera and mAbs
Rabbit antiserum A3 generated against a bacterial
fusion protein containing part of NS3 of CSFV strain
Alfort Tu¨bingen was used for immunoprecipitation of
NS3 under denaturing conditions (Thiel et al., 1991); for
detection of NS3 in Western blot analysis, hybridoma
supernatant of mouse mAb 8.12.7 (Corapi et al., 1990)
was applied. Rabbit antiserum P1 was used for immu-
noprecipitations of NS4A and NS4B (Meyers et al., 1992)
and for the detection of NS4A by Western blotting. The
NS5-specific serum used in immunoprecipitation analy-
sis was a 1:1 mixture of rabbit antisera 62D and B3B
directed against NS5A or NS5B, respectively (Collett et
al., 1988a); the latter two sera were generously provided
by M. S. Collett (ViroPharma Incorporated, Exton, PA).
The mAb directed against GST is distributed by Santa
Cruz Biotechnology (Santa Cruz, CA). Detection of pro-teins carrying the myc-tag was achieved by a tag-spe-
cific mAb purchased from Invitrogen.
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